Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects.
| Autor: | Guérard, N.1 nicolas.guerard@actelion.com, Morand, O.2, Dingemanse, J.1 |
|---|---|
| Zdroj: | Orphanet Journal of Rare Diseases. 1/14/2017, Vol. 12, p1-10. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|